Opioid Crisis Accountability Act of 2019
Latest action · May 21, 2019 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 21, 2019
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Opioid Crisis Accountability Act of 2019
This bill establishes a series of restrictions and requirements relating to opioid marketing and distribution practices.
Specifically, the bill prohibits (1) knowingly making false advertising or marketing claims regarding the addictive nature of opioids; (2) knowingly supplying communities with quantities of opioids that are not medically reasonable; or (3) failing to report distribution orders, or patterns of orders, while knowing that the orders are not being dispensed in a medically reasonable manner. Employees of opioid manufacturers and distributors are subject to civil penalties and imprisonment for violations; corporations and executives are subject to civil penalties. Manufacturers shall also lose their period of market exclusivity.
Additionally, the Department of Health and Human Services must assess a fee against each corporation that, between January 1, 1993, and the date of enactment of this bill, manufactured or distributed opioids, if such opioids were covered under a federal health program at least once during this period. Manufacturers that fail to pay the fee shall lose associated drug approval until the fee is paid in full.
The bill authorizes collected civil penalties and fees to be used for activities that address opioid misuse and abuse, including family and educational programs.
Cosponsors 3
Members who signed on, in the order they did. All signed on May 21, 2019.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CA | Kamala D. Harris | Original | May 21, 2019 |
| D-CO | Michael F. Bennet | Original | May 21, 2019 |
| D-CT | Richard Blumenthal | Original | May 21, 2019 |
Actions 2
Everything that happened, newest first.
- May 21, 2019Introduced in Senate
- May 21, 2019Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 2917 | Opioid Crisis Accountability Act of 2019 | Identical bill | May 23, 2019 |
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Child health
- Civil actions and liability
- Consumer affairs
- Corporate finance and management
- Criminal procedure and sentencing
- Drug safety, medical device, and laboratory regulation
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Government studies and investigations
- Government trust funds
- Health
- Health care coverage and access
- Health programs administration and funding
- Marketing and advertising
- Prescription drugs
- Securities
- Wages and earnings
Text 1
Each version as it was printed, newest first.
- May 21, 2019Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.